Antigen activator [Immunosaver] immunosaver-Patented in 7 countries around the world-
-In the past, the activation conditions for cell membranes and nuclei were different, but IS can be activated under the same conditions.
-The treatment method is simple, and it is not necessary to return to room temperature for a long time after heat treatment, and immunostaining can be performed immediately by washing with a buffer solution.
-Good stainability, and some antibodies can increase the dilution rate, leading to cost reduction.
-Very reproducible and stable results can be obtained.
Japanese Patent No. 3797418
U.S. Patent 6960450
European patent 1376096 (Switzerland, Germany, Denmark, United Kingdom, Netherlands)
* Comparison of primary antibody and activator (specific example of dilution ratio)
* Comparison of effects by 3 types of activation methods (cyclin D1 antibody)